AAAAAA

   
Results: 1-14 |
Results: 14
One-year survival following early revascularization for cardiogenic shock
Authors: Hochman, JS Sleeper, LA White, HD Dzavik, V Wong, SC Menon, V Webb, JG Steingart, R Picard, MH Menegus, MA Boland, J Sanborn, T Buller, CE Modur, S Forman, R Desvigne-Nickens, P Jacobs, AK Slater, JN LeJemtel, TH
Citation: Js. Hochman et al., One-year survival following early revascularization for cardiogenic shock, J AM MED A, 285(2), 2001, pp. 190-192
Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA)
Authors: Berger, PB Dzavik, V Penn, IM Catellier, D Buller, CE
Citation: Pb. Berger et al., Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA), AM HEART J, 142(5), 2001, pp. 776-781
Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA)
Authors: Dzavik, V Carere, RG Mancini, GBJ Cohen, EA Catellier, D Anderson, TE Barbeau, G Lazzam, C Title, LM Berger, PB Labinaz, M Teo, KK Buller, CE
Citation: V. Dzavik et al., Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA), AM HEART J, 142(2), 2001, pp. 301-308
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry
Authors: Webb, JG Sanborn, TA Sleeper, LA Carere, RG Buller, CE Slater, JN Baran, KW Koller, PT Talley, JD Porway, M Hochman, JS
Citation: Jg. Webb et al., Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry, AM HEART J, 141(6), 2001, pp. 964-970
Co-morbidity data in outcomes research - Are clinical data derived from administrative databases a reliable alternative to chart review?
Authors: Humphries, KH Rankin, JM Carere, RG Buller, CE Kiely, FM Spinelli, JJ
Citation: Kh. Humphries et al., Co-morbidity data in outcomes research - Are clinical data derived from administrative databases a reliable alternative to chart review?, J CLIN EPID, 53(4), 2000, pp. 343-349
Cardiogenic shock complicating acute myocardial infarction - Etiologies, management and outcome: A report from the SHOCK Trial Registry
Authors: Hochman, JS Buller, CE Sleeper, LA Boland, J Dzavik, V Sanborn, TA Godfrey, E White, HD Lim, J LeJemtel, T
Citation: Js. Hochman et al., Cardiogenic shock complicating acute myocardial infarction - Etiologies, management and outcome: A report from the SHOCK Trial Registry, J AM COL C, 36(3), 2000, pp. 1063-1070
Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: A report from the SHOCK Trial Registry
Authors: Webb, JG Sleeper, LA Buller, CE Boland, J Palazzo, A Buller, E White, HD Hochman, JS
Citation: Jg. Webb et al., Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: A report from the SHOCK Trial Registry, J AM COL C, 36(3), 2000, pp. 1084-1090
Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: A report from the SHOCK Trial Registry
Authors: Thompson, CR Buller, CE Sleeper, LA Antonelli, TA Webb, JG Jaber, WA Abel, JG Hochman, JS
Citation: Cr. Thompson et al., Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: A report from the SHOCK Trial Registry, J AM COL C, 36(3), 2000, pp. 1104-1109
Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial
Authors: Weaver, WD Reisman, MA Griffin, JJ Buller, CE Leimgruber, PP Henry, T D'Haem, C Clark, VL Martin, JS Cohen, DJ Neil, N Every, NR
Citation: Wd. Weaver et al., Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial, LANCET, 355(9222), 2000, pp. 2199-2203
Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis - The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT)
Authors: Teo, KK Burton, JR Buller, CE Plante, S Catellier, D Tymchak, V Dzavik, V Taylor, D Yokoyama, S Montague, TJ
Citation: Kk. Teo et al., Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis - The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT), CIRCULATION, 102(15), 2000, pp. 1748-1754
Early revascularization in acute myocardial infarction complicated by cardiogenic shock
Authors: Hochman, JS Sleeper, LA Webb, JG Sanborn, TA White, HD Talley, JD Buller, CE Jacobs, AK Slater, JN Col, J McKinlay, SM LeJemtel, TH
Citation: Js. Hochman et al., Early revascularization in acute myocardial infarction complicated by cardiogenic shock, N ENG J MED, 341(9), 1999, pp. 625-634
Improved clinical outcome after widespread use of coronary-artery stentingin Canada
Authors: Rankin, JM Spinelli, JJ Carere, RG Ricci, DR Penn, IM Hilton, JD Henderson, MA Hayden, RI Buller, CE
Citation: Jm. Rankin et al., Improved clinical outcome after widespread use of coronary-artery stentingin Canada, N ENG J MED, 341(26), 1999, pp. 1957-1965
Primary stenting versus balloon angioplasty in occluded coronary arteries - The total occlusion study of Canada (TOSCA)
Authors: Buller, CE Dzavik, V Carere, RG Mancini, GBJ Barbeau, G Lazzam, C Anderson, TJ Knudtson, ML Marquis, JF Suzuki, T Cohen, EA Fox, RS Teo, KK
Citation: Ce. Buller et al., Primary stenting versus balloon angioplasty in occluded coronary arteries - The total occlusion study of Canada (TOSCA), CIRCULATION, 100(3), 1999, pp. 236-242
Failed stent delivery: Importance for modern interventional cardiology
Authors: Buller, CE
Citation: Ce. Buller, Failed stent delivery: Importance for modern interventional cardiology, AM HEART J, 136(6), 1998, pp. 945-947
Risultati: 1-14 |